0024-5903 : Praluent 75 mg/ml Subcutaneous Injection, Solution


NDC: 0024-5903
Labeler: Sanofi-aventis U.S. LLC
Product Type: Human Prescription Drug
Drug Name:  Praluent
Dosage Form: Subcutaneous Injection, Solution
Application #: BLA125559
Rev. Date: 


NDC Package Codes:

  • 0024-5903-00: 1 BLISTER PACK IN 1 CARTON (0024‑5903‑00) > 1 SYRINGE, GLASS IN 1 BLISTER PACK > 1 ML IN 1 SYRINGE, GLASS
  • 0024-5903-01: 1 BLISTER PACK IN 1 CARTON (0024‑5903‑01) > 1 SYRINGE, GLASS IN 1 BLISTER PACK > 1 ML IN 1 SYRINGE, GLASS
  • 0024-5903-02: 2 BLISTER PACK IN 1 CARTON (0024‑5903‑02) > 1 SYRINGE, GLASS IN 1 BLISTER PACK > 1 ML IN 1 SYRINGE, GLASS

Active Ingredients:

  • Alirocumab

Dosage Strength:

  • 75 mg/mL

Pharmaceutical Classes:

  • PCSK9 Inhibitor [EPC]
  • PCSK9 Inhibitors [MoA]
  • Antibodies
  • Monoclonal [Chemical/Ingredient]

Related Products:

Based on records with the same trade name.
  • 0024-5901 Praluent 75 mg/ml Subcutaneous Injection, Solution by Sanofi-aventis U.S. LLC
  • 0024-5902 Praluent 150 mg/ml Subcutaneous Injection, Solution by Sanofi-aventis U.S. LLC
  • 0024-5904 Praluent 150 mg/ml Subcutaneous Injection, Solution by Sanofi-aventis U.S. LLC
  • 61755-020 Praluent 75 mg/ml Subcutaneous Injection, Solution by Regeneron Pharmaceuticals, Inc.
  • 61755-021 Praluent 150 mg/ml Subcutaneous Injection, Solution by Regeneron Pharmaceuticals, Inc.
  • 72733-5901 Praluent 75 mg/ml Subcutaneous Injection, Solution by Sanofi Us Corporation
  • 72733-5902 Praluent 150 mg/ml Subcutaneous Injection, Solution by Sanofi Us Corporation

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 0024-5903 QR Code

< Prev: 0024-5902Next: 0024-5904 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.